New Zealand Gazette – 2005 – No. 99

Page 2321

✨ Hazardous Substances Classification



29 JUNE 2005

NEW ZEALAND GAZETTE, No. 99

2321

Substance Hazard classification(s) Variation code(s)
Liquid containing 4.1 – 7% mepyramine maleate 6.1E 11
Liquid containing 3.5 – 4.5% methandriol dipropionate and 2.5 – 4% nandrolone decanoate 6.5B, 6.7B, 6.8A, 6.9B, 9.2D 4, 10, 11, 12, 18
Liquid containing 0.01 – 0.04% methscopolamine bromide and 1 – 5% neomycin sulphate 6.5B, 6.9B 10, 11
Liquid containing 1 – 9% methylprednisolone acetate 6.8B, 6.9B 11
Solid containing 14 – 24% metronidazole and 20 – 34% spiramycin 6.5B, 6.6A, 6.7B, 9.1A 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Solid containing 20 – 30% metronidazole and 39 – 50% spiramycin 6.1E, 6.5B, 6.6A, 6.7B, 9.1A 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Cream containing 0.5 – 5% miconazole 6.8B, 9.1D 11, 12, 18
Liquid containing 1 – 3% miconazole, 0.01 – 0.1% polymyxin and 0.3 – 0.7% prednisolone acetate 6.8B 11
Solid containing 1.7 – 2.4% milbemycin and 18 – 24% praziquantel 6.1E, 6.9B, 9.1A, 9.2C, 9.4B 4, 5, 6, 7, 13, 17, 19, 23
Solid containing 2.6 – 3.9% milbemycin and 6 – 10% praziquantel 6.9B, 9.1A, 9.2B, 9.4A 4, 5, 6, 7, 13, 17, 19, 23
Liquid containing 30 – 35 g/litre monensin sodium 6.1C, 6.3B, 6.5B, 8.3A, 9.1C, 9.2D, 9.3B 4, 8, 11, 12, 17, 30
Liquid containing 50 – 70 g/litre monensin sodium 6.1B, 6.5B, 8.3A, 9.1D, 9.2D, 9.3A 4, 8, 11, 12, 16, 17, 29
Solid containing 100 – 250 g/kg monensin sodium 6.1B, 6.3B, 6.5B, 8.3A, 9.1D, 9.2D, 9.3A 4, 8, 11, 12, 16, 17, 28
Capsule containing 400 – 500 g/kg monensin sodium 6.1A, 6.3B, 6.5B, 8.3A, 9.1A, 9.2B, 9.3A 4, 5, 6, 8, 11, 12, 15, 17, 27, 31
Solid containing 850 – 950 g/kg monensin sodium 6.1A, 6.3A, 6.5B, 8.3A, 9.1A, 9.2B, 9.3A 4, 9, 11, 12, 14, 26
Solid containing 25 – 40 g/kg morantel citrate 6.1E, 6.4A, 6.9B, 9.1A, 9.4C 4, 5, 6, 7, 13, 17, 31
Liquid containing 1 – 2 g/litre moxidectin (Substance A) 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4C 4, 7, 10, 13, 17
Liquid containing 1 – 2 g/litre moxidectin (Substance B) 6.5B, 6.8B, 6.8C, 9.1A, 9.4C 4, 7, 10, 13, 17
Liquid containing 1 – 1.3% moxidectin 6.1E, 6.5B, 6.8B, 6.8C, 6.9B, 9.1A, 9.2C, 9.4B 4, 7, 10, 13, 17
Liquid containing 1.6 – 2% moxidectin 6.1D, 6.5B, 6.8B, 6.8C, 6.9B, 9.1A, 9.2C, 9.3C, 9.4B 4, 7, 10, 13, 17
Liquid containing 2.6 – 6 g/litre moxidectin (Substance A) 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4B 4, 7, 10, 13, 17
Liquid containing 2.6 – 6 g/litre moxidectin (Substance B) 6.3B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4B 4, 7, 13, 17
Liquid containing 1 – 1.5 g/litre moxidectin and 16 – 22 g/litre praziquantel 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4C 4, 7, 10, 13, 17


Next Page →



Online Sources for this page:

VUW Te Waharoa — PDF NZ Gazette 2005, No 99


Gazette.govt.nz — PDF NZ Gazette 2005, No 99




✨ LLM interpretation of page content

🏥 Schedule of Veterinary Medicines Transferred under Hazardous Substances Act (continued from previous page)

🏥 Health & Social Welfare
Veterinary Medicines, Hazardous Substances, Transfer Schedule, Regulatory Changes, Levamisole Hydrochloride